The effect of TRIM5 variants on the susceptibility to HIV‐1 infection and disease progression in the Polish population

Abstract

AbstractBackgroudTripartite motif containing 5α protein is a factor contributing to intracellular defense mechanisms against human immunodeficiency virus‐1 (HIV‐1) infection. The studies of TRIM5 variants effects on the risk of HIV‐1 infection and the clinical course of disease provided inconclusive results in different ethnic groups. The aim of this study was to investigate the influence of TRIM5 variants on susceptibility to HIV‐1 infection and clinical parameters among Polish HIV‐1‐infected patients.Materials & MethodsIn our study, we investigated 301 HIV‐1‐infected patients and 186 age‐matched seronegative controls. Seven variants of the TRIM5 gene (rs7127617, rs3824949, rs3740996, rs11601507, rs10838525, rs11038628, and rs28381981) were genotyped using both sequencing and polymerase chain reaction‐restriction fragment length polymorphism (PCR‐RFLP) techniques.Results and ConclusionsThe frequencies of rs7127617 TT genotype and T allele occurrence were lower in HIV‐1‐infected subjects compared to controls (0.14 vs. 0.26 for T/T genotype and 0.45 vs. 0.54 for T allele), suggesting their possible protective effect (p = 0.005 and p = 0.007, respectively). Heterozygosity and presence of the T allele at rs3740996 were enriched in controls compared to HIV‐1‐infected group (0.19 vs. 0.12 for C/T genotype and 0.11 vs. 0.07 for T allele; p = 0.03 and p = 0.02, respectively). Moreover, rs3824949 CC genotype carriers had a lower viral load than patients bearing rs3824949 GG/CG genotypes (4.0 vs. 4.6 log copies/mL; p = 0.049); however, none of the variants affected CD4+ cell count. In conclusion, our data confirm the role of TRIM5 variants in the HIV‐1 transmission and the clinical course of HIV‐1 infection. The presence of rs7127617 TT genotype and T allele seems to protect against HIV‐1 transmission in examined population.